<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://gutsandgrowth.com/2026/05/22/glp-1-receptor-agonists-and-eating-disorders-cause-for-concern/</loc><news:news><news:publication><news:name>gutsandgrowth</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date><news:title>&#8220;GLP-1 Receptor Agonists and Eating Disorders — Cause for Concern&#8221;</news:title><news:keywords>anorexia nervosa, eating disorder, GLP-1 RA, eye stroke</news:keywords></news:news></url><url><loc>https://gutsandgrowth.com/2026/05/21/beneficial-off-target-effect-upadacitinib-improved-eosinophilic-esophagitis-case-report/</loc><news:news><news:publication><news:name>gutsandgrowth</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-21T11:00:00+00:00</news:publication_date><news:title>Beneficial Off-Target Effect: Upadacitinib Improved Eosinophilic Esophagitis (Case Report)</news:title><news:keywords>Eosinophilic esophagitis, Upadacitinib, dupilumab, dupixent</news:keywords></news:news></url></urlset>
